Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
36 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
OOGARTSEN SL from Gent, company number BE0676677146, closed financial year 2025 with a result of € 9,609 after tax. For that financial year OOGARTSEN SL recorded a gross margin of € 12,922 and equity of € 16,333. Compared with financial year 2024, the result moved from € 7,896 to € 9,609. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 9, 2026.
€ 16,333
▲ 143% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 9,609
▲ 22% vs 2024
Profit after tax over the fiscal year.
€ 46,933
▲ 7% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 5,333.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,450
▼ 89% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 6,428 | € 7,685 | € 10,728 | € 12,922 | ▲ 20% |
| Profit after taxes | € -8,823 | € 2,568 | € 7,896 | € 9,609 | ▲ 22% |
| Equity | € -2,639 | € -72 | € 6,724 | € 16,333 | ▲ 143% |
| Total debts | € 36,774 | € 48,476 | € 45,729 | € 36,347 | ▼ 21% |
| Cash | € 24,143 | € 36,822 | € 44,030 | € 46,933 | ▲ 7% |
| Retained profit | € -14,739 | € -12,172 | € -4,276 | € 5,333 | ▲ € 9,609 |
| Balance sheet total | € 34,134 | € 48,405 | € 52,453 | € 52,680 |
Key figures of OOGARTSEN SL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to OOGARTSEN SL?
What happened at OOGARTSEN SL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 9,609 (▲ 22% vs 2024). Source: NBB ↗
- Lotte Loret became a director. NBB
- Leigh Spielberg became a director. NBB
- Ann-Sofie Schauwvlieghe became a director. NBB
- Ozlem Köse became a director. NBB
- New establishment in Gent. KBO
- Steven Van Slycken became a director. NBB
- Philippe Kestelyn became a director. NBB
In short
From € 8,823 loss in 2022 to € 9,609 profit in 2025.
Best year ever: 2025, with € 9,609 profit.
A new publication or filing at OOGARTSEN SL? We notify you, reason included.
Follow OOGARTSEN SLDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of OOGCHIRURGIE DR. VAN SLYCKEN -DR.CANDAELE, Dr. Lotte Loret - Oftalmologie comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
OOGARTSEN SLBehind OOGARTSEN SL are Lotte Loret, Steven Van Slycken, Leigh Spielberg, Philippe Kestelyn, Jan Poelman and Pierre Schauwvlieghe. The shares are held by OOGCHIRURGIE DR. VAN SLYCKEN -DR.CANDAELE (16.7%) and Dr. Lotte Loret - Oftalmologie (10%).
Directors
According to the 2025 annual accounts
since 2023
Steven Van Slycken
Managing director
since 2017
Leigh Spielberg
Director
since 2023
Philippe Kestelyn
Director
since 2017
Jan Poelman
Managing director
since 2017
since 2023
Guy Vereecken
Director
since 2017
Ozlem Köse
Director
since 2023
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Groenebriel 1
9000 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 36 companies are registered at this address.
All companies at this address →Palliatieve Zorg Sint-Vincentius
Geneesheren Sint-Lucas Gent
AZ Sint-Lucas & Volkskliniek
DOKTER CHRISTEL TUYTTENS
€ 331,618 gross margin · 2025
SINT-LUCAS ZELZATE
+31 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0676.677.146
- VAT number
- BE 0676.677.146
- Registered office
- Groenebriel 1, 9000 Gent
- Names & denominations
- OOGARTSEN SL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 June 2017
- Peppol
- Active · Active since 26 Nov 2024
- Activities · NACE
Activiteiten op het gebied van voeding
Overige menselijke gezondheidszorg, n.e.g.